Difference between revisions of "Tyagi S, et al. J. Adv. Pharm. Technol. Res. (2011) cited as Ref 382 in DOI: 10.1038/s41392-020-0110-5 (Q9645)"
Jump to navigation
Jump to search
(Created claim: DOI Identifier (P138): 10.4103/2231-4040.90879, #quickstatements; #temporary_batch_1590000649558) |
(Created claim: PubMed ID (P140): 22247890, #quickstatements; #temporary_batch_1590001671040) |
||
| Property / PubMed ID | |||
| + | |||
| Property / PubMed ID: 22247890 / rank | |||
| + | Normal rank | ||
Revision as of 19:15, 20 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Tyagi S, et al. J. Adv. Pharm. Technol. Res. (2011) cited as Ref 382 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Tyagi S
0 references
Gupta P
0 references
Saini AS
0 references
